dm+d
414428000
Articles
Hydromorphone products: information for supporting intrathecal risk assessment
11 August 2022Hydromorphone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Estimating dose equivalence from oral morphine to other opioids
14 September 2021Use our tool to obtain approximate dose equivalences of oral morphine to other oral opioids and help you calculate an estimated equivalent dose
Switching between oral morphine and other oral opioids in adult palliative cancer care patients
14 September 2021Switching between morphine and alternative opioids requires care and thoughtful application of a stepped process
Medicine Compliance Aid Stability
PalladoneNapp Pharmaceuticals Ltd
Napp Pharmaceuticals Ltd
Palladone
Capsules - various strengths
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from light and store in airtight containers.
17 November 2022
Palladone SRNapp Pharmaceuticals Ltd
Napp Pharmaceuticals Ltd
Palladone SR
Capsules m/r - various strengths
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from light and store in airtight containers.
17 November 2022
Lactation Safety Information
Morphine or other appropriate analgesic
Limited published evidence of safety
Small amounts in breast milk
Case report of sedation, severe apnoea and bradycardia in a breastfed infant
15 September 2019